Indonesia DIA-RAMADAN Study: A Real-life, Prospective and Observational of Gliclazide MR in Type-2 Diabetes patients During Ramadan Fasting

• Main Authors: Soebagijo Adi Soelistijo, Soebagijo, Andi Makbul Aman, -, Hendra Zufry, -, Agung Pranoto, -, Achmad Rudijanto, -, Mohamed Hassanien, -
• Format: Article PeerReviewed
• Language: English; Indonesian; English; English
• Published: Indonesian Society of Internal Medicine
• Subjects: R5-920 Medicine (General)
• Online Access: https://repository.unair.ac.id/130887/1/01.%20Artikel.pdf; https://repository.unair.ac.id/130887/2/1karil.pdf; https://repository.unair.ac.id/130887/3/01.%20turnitin.pdf; https://repository.unair.ac.id/130887/4/01.%20korespondensi.pdf; https://repository.unair.ac.id/130887/; https://actamedindones.org/index.php/ijim/article/view/1758
• Institution: Universitas Airlangga

Background: Sulfonylureas (SUs) have been widely used in many countries for T2DM treatment. Gliclazide is one of the SUs with the lowest risk of hypoglycemia; however, the safety and effectiveness of gliclazide MR during Ramadan has not yet been reported in Indonesia. This study aimed to assess safe...